Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice.
about
Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.Biomarkers in congenital heart disease: do natriuretic peptides hold the key?The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability.NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases.Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure.Relation of body fluid status to B-type natriuretic peptide levels in patients with chronic heart failure during long-term follow-up.Prognostic prediction in acute heart failure patients with extreme BNP values.Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.
P2860
Q33227738-2A3A7646-A7F9-43FF-A3EE-B92E25469AD1Q33292472-99B336E3-62CB-49EC-9515-FE8963DE3A2FQ35584237-1248FAC1-685E-4394-8DD7-37BB43BCDA9CQ38113254-7C62B438-BD8C-4E3F-BFF4-5E6165C61C57Q43043848-5D137BCC-807F-473C-B4B3-F0EFEB25AD8DQ45129483-2A8C226E-A28E-4BD7-AC1E-25656216EDD5Q46678287-D1FA4523-3FAD-4748-828B-382EC79A27D2Q47402744-859897CE-3FB1-473C-A58E-51A8EBEC2148Q48030240-3F191784-2946-4B69-B96F-7428CF38AA6CQ48266129-A5465E4D-7AAA-49E1-9BAF-80BB8F9C2874Q48388077-9A1640A5-D748-4AFC-A77E-D95A6230F7A8Q53541503-2DD8A1FD-BEB4-4634-81DA-172A7AF159D1Q54330038-CB8D8056-21F5-45C3-A7EF-1AEBC089F596Q55019304-8ACE0852-529C-442A-B5D8-2758CE892922
P2860
Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Plasma brain natriuretic pepti ...... t failure in general practice.
@en
Plasma brain natriuretic pepti ...... t failure in general practice.
@nl
type
label
Plasma brain natriuretic pepti ...... t failure in general practice.
@en
Plasma brain natriuretic pepti ...... t failure in general practice.
@nl
prefLabel
Plasma brain natriuretic pepti ...... t failure in general practice.
@en
Plasma brain natriuretic pepti ...... t failure in general practice.
@nl
P2093
P2860
P1476
Plasma brain natriuretic pepti ...... t failure in general practice.
@en
P2093
A Mark Richards
Eric Espiner
G Ian Town
Graham McGeoch
John Lainchbury
P2860
P304
P356
10.1016/S1388-9842(02)00027-2
P577
2002-08-01T00:00:00Z